- Home
- AIN vs ATAI Comparison
AIN vs ATAI Comparison
Compare AIN & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIN
- ATAI
- Stock Information
- Founded
- AIN 1895
- ATAI 2018
- Country
- AIN United States
- ATAI Netherlands
- Employees
- AIN N/A
- ATAI N/A
- Industry
- AIN Textiles
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- AIN Consumer Discretionary
- ATAI Health Care
- Exchange
- AIN Nasdaq
- ATAI Nasdaq
- Market Cap
- AIN 1.7B
- ATAI 1.6B
- IPO Year
- AIN 1987
- ATAI 2021
- Fundamental
- Price
- AIN $47.82
- ATAI $4.34
- Analyst Decision
- AIN Hold
- ATAI Strong Buy
- Analyst Count
- AIN 4
- ATAI 5
- Target Price
- AIN $64.25
- ATAI $14.00
- AVG Volume (30 Days)
- AIN 365.9K
- ATAI 7.6M
- Earning Date
- AIN 11-05-2025
- ATAI 11-14-2025
- Dividend Yield
- AIN 2.24%
- ATAI N/A
- EPS Growth
- AIN N/A
- ATAI N/A
- EPS
- AIN N/A
- ATAI N/A
- Revenue
- AIN $1,148,512,000.00
- ATAI $2,309,000.00
- Revenue This Year
- AIN N/A
- ATAI $736.04
- Revenue Next Year
- AIN $3.93
- ATAI N/A
- P/E Ratio
- AIN N/A
- ATAI N/A
- Revenue Growth
- AIN N/A
- ATAI 510.85
- 52 Week Low
- AIN $47.65
- ATAI $1.15
- 52 Week High
- AIN $88.13
- ATAI $6.75
- Technical
- Relative Strength Index (RSI)
- AIN 23.78
- ATAI 33.90
- Support Level
- AIN $51.15
- ATAI $4.14
- Resistance Level
- AIN $56.91
- ATAI $5.91
- Average True Range (ATR)
- AIN 2.48
- ATAI 0.38
- MACD
- AIN -0.86
- ATAI -0.23
- Stochastic Oscillator
- AIN 1.14
- ATAI 6.82
About AIN Albany International Corporation
Albany International Corp is principally engaged in processing textiles and materials. The company consists of two business segments, the machine clothing segment, which produces and provides custom-designed fabrics and belts for the production in the paper, nonwovens, and other process industries; and the Albany engineered composites segment, which offers engineered composite parts for the aerospace and defensive industries. The machine clothing segment contributes to the majority of the company's total revenue. The company has an operation and generates revenue from the United States, Switzerland, Brazil, China, Mexico, France, and other areas.
About ATAI ATAI Life Sciences N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.